search
Back to results

A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.

Primary Purpose

COVID-19

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
COVID-19 Self testing and related messaging
Sponsored by
PATH
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for COVID-19 focused on measuring COVID 19, Self-Test, Pandemic Preparedness, Infectious diseases

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Above the age of 18 years, irrespective of gender and past COVID-19 status Registered with participating institutions Able and willing to provide informed consent Owns a smartphone capable of downloading the SURE STATUS app for uploading results Able to read the instructions in the Mizo or English or Hindi Exclusion Criteria: Does not consent. Has any contraindication to nasal sample collection, including recent nasal injury, nasal surgeries. Personnel who are directly involved in the conduct of the study, e.g., investigator, sub-investigator, research assistant, pharmacist, study coordinator or anyone mentioned in the delegation log.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Study participants

    Arm Description

    The study procedure is universal to all the participants from both the institutes. There are no control arms defined separately. The groups within the participants include - include health care workers, non-medical hospital staff and medical students at ZMC; and faculty, students and supporting staff at the Pacchunga University College.

    Outcomes

    Primary Outcome Measures

    Utilization rate
    Individual level: the proportion of tests each individual uses till the end of the follow-up period from the minimum number of tests allocated to them. Sample-level: mean and standard deviations calculated based on the individual utilisation rates
    Adherence Rate
    Individual level: the proportion of tests an individual performs according to the testing schedule over the total number of tests they perform. Sample-level: mean and standard deviations calculated based on the individual adherence rates
    Preferences of participants on self testing
    Proportion of preference to assisted vs unassisted self-testing
    Observation proportions of participants on self testing
    Proportion of preference to observed vs unobserved self-testing
    Time to dropout
    The time to drop out will be the time from enrolment of the participant till drop-out
    Acceptability of COVID-19 self-testing kits
    A composite indicator based on ease of use of COVID-19 self-testing kits, ease of interpretation of test results, and recommendation to others

    Secondary Outcome Measures

    Full Information

    First Posted
    November 9, 2022
    Last Updated
    November 16, 2022
    Sponsor
    PATH
    Collaborators
    UNITAID, Zoram Medical College (ZMC), Pacchunga University College, Association for Leprosy Education Rehabilitation & Treatment India (ALERT India), Government of Mizoram
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05614388
    Brief Title
    A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.
    Official Title
    A Study on Utilization, Adherence, and Acceptability of Voluntary Routine COVID-19 Self-testing Among Students, Staff and Health Workers at Two Institutions in Mizoram, India.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 2022 (Anticipated)
    Primary Completion Date
    April 2023 (Anticipated)
    Study Completion Date
    May 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    PATH
    Collaborators
    UNITAID, Zoram Medical College (ZMC), Pacchunga University College, Association for Leprosy Education Rehabilitation & Treatment India (ALERT India), Government of Mizoram

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This interventional study aims to evaluate the utilization, adherence, and acceptability of voluntary, free, routine self-testing for COVID-19 (Corona Virus (19) Disease) and related information, education and communication (IEC) messages in two institutional settings in Mizoram, India. In addition, it will assess and measure preferences for assisted vs unassisted and observed vs unobserved self-testing, assess adherence and measure dropout rate and describe dropout characteristics. The research questions it aims to address are - What is the uptake and adherence of voluntary, free, routine self-testing for COVID-19 and related IEC messages vy students, employees, and healthcare workers in two institutional settings in India? Are there any dropouts from routine self-testing and what are the factors related to dropouts? What is the preferred mode of self-testing- observed or unobserved, assisted or unassisted? Do these preferences change over time? The researchers will be measuring - Utilization rate, Adherence rate, Proportion of preference to assisted vs unassisted self-testing, Proportion of preference to observed vs unobserved self-testing, Time to dropout and Acceptability of COVID-19 self-testing kits.
    Detailed Description
    Testing is a critical component of the pandemic response. It serves two purposes; for clinical purposes, it focuses on identifying disease in symptomatic patients, while testing for epidemiological purposes, spread in the population is also assessed. India uses a mix of both Reverse Transcriptase Polymerase Chain Reaction (RT PCR) and Antigen Rapid Diagnostic Tests (Ag RDTs) for COVID-19 testing. RT PCR is the reference standard test for detection of the virus. However, not all facilities have RT PCR, and many communities have poor access. This leads to a long turn-around time (TAT) for the results to be obtained and a high load on RT PCR facilities. Hence, to prevent the spread of the virus, cases must get detected early. At the peak of the first wave of the pandemic in the country, Ag RDTs constituted close to 50% of all the tests conducted in the country. Self-testing for COVID-19 has emerged as a viable complementary testing modality. The use of self-testing kits while ensuring the availability of other COVID-19 tests at the nearest point of care addresses many of the usual barriers to uptake of services, leading to timely testing of individuals, diagnosis, and access to care. It can also reduce the burden on existing testing infrastructure especially during a surge in the cases. It also reduces overcrowding at testing facilities thereby reducing the risk of disease transmission. To improve access to testing and prevent overreliance on RT PCR laboratories, the Indian Council of Medical Research (ICMR) approved and validated the use of COVID-19 self-testing kits. As of March 2022, sixteen self-testing kits have been validated in India of which 10 are found to be satisfactory. While there are many benefits to self-testing, it is also essential to understand the utilization of the self-testing strategy, including whether or not the community can follow the steps for self-testing and what support, if any, the community may require to use self-test kits. The present study proposes the demonstration of ICMR and US-FDA (United States Food & Drug Administration) approved SURE STATUS self-testing kit in the healthcare workers and educational institution setting in Mizoram for a period of 5 months. With the ease of lockdown and movement restrictions, workplaces and educational institutes are gradually opening up. However, with the threat of the pandemic still looming large, it is prudent to put in place systems for regular screening within these settings to promote early diagnosis and care and prevent outbreaks. COVID-19 self-test has been identified as one way any institution can scale up COVID-19 testing to improve COVID-19 status awareness by reaching out to as many people as possible at a given point of time. While COVID-19 self-tests are available and widely used in India, these kits are largely used within the confines of individual homes. It is learnt that the reporting of the results of the self-test is poor as compared to the utilization of the self-test kits. To the investigator's knowledge, no study has been conducted in India to assess the utilization of self-testing as a routine procedure in places of mass indoor gathering, like workplaces and educational institutions. To address this gap, the investigators will conduct a study to evaluate the utilization, adherence, and acceptability of routine COVID-19 self-testing among students, employees and healthcare workers in two congregate settings: one University College and one Medical College and Hospital in Mizoram, India. The proposed study will document challenges, if any, in reporting of self-test results and document the key processes in operationalizing routine COVID-19 self-testing among students, employees and healthcare workers and provide learning and recommendations for systematic use of self-tests for future models of institution based COVID-19 self-testing in congregate settings.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    COVID-19
    Keywords
    COVID 19, Self-Test, Pandemic Preparedness, Infectious diseases

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    The participants include health care workers, non-medical hospital staff and medical students at ZMC; and faculty, students and supporting staff at the Pacchunga University College. All these groups will be participating in the study simultaneously. The study results will be compared for all these 6 groups.
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    646 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Study participants
    Arm Type
    Experimental
    Arm Description
    The study procedure is universal to all the participants from both the institutes. There are no control arms defined separately. The groups within the participants include - include health care workers, non-medical hospital staff and medical students at ZMC; and faculty, students and supporting staff at the Pacchunga University College.
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    COVID-19 Self testing and related messaging
    Intervention Description
    Provisioning of voluntary, free self-testing for COVID-19 (approved and validated in the country) and related Information, Education and Communication (IEC) messages
    Primary Outcome Measure Information:
    Title
    Utilization rate
    Description
    Individual level: the proportion of tests each individual uses till the end of the follow-up period from the minimum number of tests allocated to them. Sample-level: mean and standard deviations calculated based on the individual utilisation rates
    Time Frame
    5 Months
    Title
    Adherence Rate
    Description
    Individual level: the proportion of tests an individual performs according to the testing schedule over the total number of tests they perform. Sample-level: mean and standard deviations calculated based on the individual adherence rates
    Time Frame
    5 Months
    Title
    Preferences of participants on self testing
    Description
    Proportion of preference to assisted vs unassisted self-testing
    Time Frame
    5 Months
    Title
    Observation proportions of participants on self testing
    Description
    Proportion of preference to observed vs unobserved self-testing
    Time Frame
    5 Months
    Title
    Time to dropout
    Description
    The time to drop out will be the time from enrolment of the participant till drop-out
    Time Frame
    5 Months
    Title
    Acceptability of COVID-19 self-testing kits
    Description
    A composite indicator based on ease of use of COVID-19 self-testing kits, ease of interpretation of test results, and recommendation to others
    Time Frame
    5 Months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Above the age of 18 years, irrespective of gender and past COVID-19 status Registered with participating institutions Able and willing to provide informed consent Owns a smartphone capable of downloading the SURE STATUS app for uploading results Able to read the instructions in the Mizo or English or Hindi Exclusion Criteria: Does not consent. Has any contraindication to nasal sample collection, including recent nasal injury, nasal surgeries. Personnel who are directly involved in the conduct of the study, e.g., investigator, sub-investigator, research assistant, pharmacist, study coordinator or anyone mentioned in the delegation log.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Muneer Kutty, MPH
    Phone
    +919999798283
    Email
    mkutty@path.org
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jane Ralte, MD
    Organizational Affiliation
    Zoram Medical College
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    We do not plan to share any individual participant data. We will share collective learnings on various parameters at both the sites.

    Learn more about this trial

    A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.

    We'll reach out to this number within 24 hrs